# Filing Detail

Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-24-097737
Filing Date
2024-11-14
Accepted
2024-11-14 06:37:00
Documents
89

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REGISTRATION STATEMENT | ea0220567-s1_orukatherap.htm iXBRL | S-1 | 2374163
2 | OPINION OF GIBSON, DUNN & CRUTCHER LLP | ea022056701ex5-1_oruka.htm | EX-5.1 | 8528
3 | CONSENT OF PRICEWATERHOUSECOOPERS LLP | ea022056701ex23-1_oruka.htm | EX-23.1 | 1932
4 | FILING FEE TABLE | ea022056701ex-fee_oruka.htm | EX-FILING FEES | 60880
5 | GRAPHIC | image_001.jpg | GRAPHIC | 19403
6 | GRAPHIC | image_002.jpg | GRAPHIC | 373211
7 | GRAPHIC | image_003.jpg | GRAPHIC | 494200
8 | GRAPHIC | image_004.jpg | GRAPHIC | 287345
9 | GRAPHIC | image_005.jpg | GRAPHIC | 207106
10 | GRAPHIC | image_006.jpg | GRAPHIC | 518753
11 | GRAPHIC | image_007.jpg | GRAPHIC | 532091
12 | GRAPHIC | image_008.jpg | GRAPHIC | 373835
13 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 2675
| Complete submission text file | 0001213900-24-097737.txt |  | 15137904

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | orka-20240930.xsd | EX-101.SCH | 72301
15 | XBRL CALCULATION FILE | orka-20240930_cal.xml | EX-101.CAL | 33678
16 | XBRL DEFINITION FILE | orka-20240930_def.xml | EX-101.DEF | 368321
17 | XBRL LABEL FILE | orka-20240930_lab.xml | EX-101.LAB | 602047
18 | XBRL PRESENTATION FILE | orka-20240930_pre.xml | EX-101.PRE | 379028
91 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0220567-s1_orukatherap_htm.xml | XML | 782652

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283212 | Film No.: 241456990
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)